SIGA Reports Financial Results for Three Months Ended March 31, 2024
07 mai 2024 16h05 HE
|
SIGA Technologies Inc.
Generated Product Sales of $24 Million and Pre-tax Operating Income of $11 MillionCorporate Update Conference Call Today at 4:30 PM ET NEW YORK, May 07, 2024 (GLOBE NEWSWIRE) -- SIGA Technologies,...
SIGA Technologies to Host Business Update Call on May 7 Following Release of First-Quarter 2024 Financial Results
01 mai 2024 17h00 HE
|
SIGA Technologies Inc.
NEW YORK, May 01, 2024 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (NASDAQ: SIGA), a commercial-stage pharmaceutical company, today announced that management will host a webcast and...
SIGA Amends International Promotion Agreement with Meridian to Enhance International Growth Opportunities of Oral TPOXX®
01 avr. 2024 16h05 HE
|
SIGA Technologies Inc.
NEW YORK, April 01, 2024 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (NASDAQ: SIGA), a commercial-stage pharmaceutical company focused on health security and infectious disease, announced today that...
SIGA Names Larry Miller General Counsel
25 mars 2024 07h30 HE
|
SIGA Technologies Inc.
NEW YORK, March 25, 2024 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (NASDAQ: SIGA), a commercial-stage pharmaceutical company focused on health security and infectious diseases, announced the...
SIGA Reports Financial Results for Three and Twelve Months Ended December 31, 2023
12 mars 2024 16h05 HE
|
SIGA Technologies Inc.
• Increased Product Sales to $131 Million in 2023 • Grew Pre-tax Operating Income to $84 Million in 2023 • Declared Today a Special Cash Dividend of $0.60 per Share • Corporate Update Conference...
SIGA Declares Special Cash Dividend of $0.60 Per Share
12 mars 2024 07h30 HE
|
SIGA Technologies Inc.
NEW YORK, March 12, 2024 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (NASDAQ: SIGA), a commercial-stage pharmaceutical company, today announced that its board of directors declared a special...
SIGA Technologies to Host Business Update Call on March 12th, 2024 Following Release of Fourth Quarter and Full Year 2023 Financial Results
05 mars 2024 07h30 HE
|
SIGA Technologies Inc.
NEW YORK, March 05, 2024 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (NASDAQ: SIGA), a commercial-stage pharmaceutical company, today announced that management will host a webcast and...
SIGA Announces Appointment of Diem Nguyen, Ph.D., MBA, as New Chief Executive Officer
22 janv. 2024 07h30 HE
|
SIGA Technologies Inc.
NEW YORK, Jan. 22, 2024 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (NASDAQ: SIGA), a commercial-stage pharmaceutical company focused on the health security market, today announced that Diem...
SIGA Reports Financial Results for Three and Nine Months Ended September 30, 2023
07 nov. 2023 16h05 HE
|
SIGA Technologies Inc.
- In Third Quarter, SIGA Received U.S. Government Orders for Approximately $113 Million of Oral TPOXX and $25 Million of IV TPOXX® - - In October, Joint Procurement Framework Contract was signed by...
SIGA Technologies to Host Business Update Call on November 7th, 2023 Following Release of Third Quarter 2023 Financial Results
26 oct. 2023 07h30 HE
|
SIGA Technologies Inc.
NEW YORK, Oct. 26, 2023 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (NASDAQ: SIGA), a commercial-stage pharmaceutical company, today announced that management will host a webcast and...